These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials. Ahani B; Tuffy KM; Aksyuk AA; Wilkins D; Abram ME; Dagan R; Domachowske JB; Guest JD; Ji H; Kushnir A; Leach A; Madhi SA; Mankad VS; Simões EAF; Sparklin B; Speer SD; Stanley AM; Tabor DE; Hamrén UW; Kelly EJ; Villafana T Nat Commun; 2023 Jul; 14(1):4347. PubMed ID: 37468530 [TBL] [Abstract][Full Text] [Related]
3. A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus. Hu L; Jiang J; Tang Y; Mei L; Wu L; Li L; Chen H; Long F; Xiao J; Peng T Viruses; 2023 Jul; 15(7):. PubMed ID: 37515234 [TBL] [Abstract][Full Text] [Related]
4. Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000-2022). Riccò M; Corrado S; Palmieri S; Marchesi F Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508666 [TBL] [Abstract][Full Text] [Related]
5. Why has the epidemiology of RSV changed during the COVID-19 pandemic? Abu-Raya B; Viñeta Paramo M; Reicherz F; Lavoie PM EClinicalMedicine; 2023 Jul; 61():102089. PubMed ID: 37483545 [TBL] [Abstract][Full Text] [Related]
6. Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results. Oey A; McClure M; Symons JA; Chanda S; Fry J; Smith PF; Luciani K; Fayon M; Chokephaibulkit K; Uppala R; Bernatoniene J; Furuno K; Stanley T; Huntjens D; Witek J; PLoS One; 2023; 18(7):e0288271. PubMed ID: 37467213 [TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection in the elderly. Mlinaric-Galinovic G; Falsey AR; Walsh EE Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):777-81. PubMed ID: 9072495 [TBL] [Abstract][Full Text] [Related]
8. Comparison of sinonasal symptoms in upper respiratory tract infections during the infectious diseases season of November 2023 to March 2024-a cross-sectional study. Straburzyński M; Romaszko-Wojtowicz A Front Med (Lausanne); 2024; 11():1447467. PubMed ID: 39267977 [TBL] [Abstract][Full Text] [Related]
9. Inter-societal Delphi Consensus on the topical nasal treatments in Italy. Varricchio A; Presutti L; La Mantia I; Ciprandi G Multidiscip Respir Med; 2024 Sep; 19(1):. PubMed ID: 39229922 [TBL] [Abstract][Full Text] [Related]
10. Psychological stress and susceptibility to the common cold. Cohen S; Tyrrell DA; Smith AP N Engl J Med; 1991 Aug; 325(9):606-12. PubMed ID: 1713648 [TBL] [Abstract][Full Text] [Related]
11. Vitamin C for preventing and treating the common cold. Douglas RM; Hemila H; D'Souza R; Chalker EB; Treacy B Cochrane Database Syst Rev; 2004 Oct; (4):CD000980. PubMed ID: 15495002 [TBL] [Abstract][Full Text] [Related]
12. Effects on the nasal mucosa of upper respiratory viruses (common cold). Winther B Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434 [TBL] [Abstract][Full Text] [Related]
13. Social ties and susceptibility to the common cold. Cohen S; Doyle WJ; Skoner DP; Rabin BS; Gwaltney JM JAMA; 1997 Jun; 277(24):1940-4. PubMed ID: 9200634 [TBL] [Abstract][Full Text] [Related]
14. Common cold. Eccles R Front Allergy; 2023; 4():1224988. PubMed ID: 37426629 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility to the common cold virus is associated with day length. Wyse CA; Clarke AC; Nordon EA; Murtagh C; Keogh AA; Lopez LM iScience; 2022 Aug; 25(8):104789. PubMed ID: 35982792 [TBL] [Abstract][Full Text] [Related]
17. Human bocavirus 1 is a genuine pathogen for acute respiratory tract infection in pediatric patients determined by nucleic acid, antigen, and serology tests. De R; Zhang KX; Wang F; Zhou YT; Sun Y; Chen DM; Zhu RN; Guo Q; Liu S; Qu D; Qian Y; Zhao LQ Front Microbiol; 2022; 13():932858. PubMed ID: 35966673 [TBL] [Abstract][Full Text] [Related]